or Try an Advanced Search...

    Technical Analysis for JSPR - Jasper Therapeutics, Inc

    Grade Last Price % Change Price Change
    C 23.14 1.94% 0.44
    JSPR closed up 1.94 percent on Monday, July 1, 2024, on 84 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Up
    Historical JSPR trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Up 3 Days in a Row Strength 0.00%
    50 DMA Resistance Bearish 1.94%
    Pocket Pivot Bullish Swing Setup 1.94%
    Volume Surge Other 1.94%
    Slingshot Bearish Bearish Swing Setup 5.13%
    Lower Bollinger Band Walk Weakness 5.13%
    Gapped Up Strength 5.13%
    Gilligan's Island Buy Setup Bullish Swing Setup 10.30%
    Older End-of-Day Signals for JSPR ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 7 hours ago
    Down 3% about 7 hours ago
    Down 2 % about 7 hours ago
    Down 1% about 7 hours ago
    Fell Below 10 DMA about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    JSPR Chart by TradingView
    Basic chart:

    Profile

    Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Stem Cell Gene Therapy Transplantation Bone Marrow Hematopoietic Stem Cell

    Is JSPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jun 17 Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
    Jun 14 Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
    Jun 9 Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation
    May 30 Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
    May 29 Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
    May 13 Jasper Therapeutics Announces Briquilimab Development Program in Asthma
    May 7 Jasper Therapeutics to Present at Upcoming Investor Conferences in May
    Mar 28 RBC starts Jasper Therapeutics at outperform, cites market opportunity
    Mar 21 Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
    See more JSPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 31.01
    52 Week Low 4.0
    Average Volume 111,299
    200-Day Moving Average 15.65
    50-Day Moving Average 23.08
    20-Day Moving Average 23.56
    10-Day Moving Average 22.41
    Average True Range 1.62
    RSI (14) 49.75
    ADX 18.25
    +DI 22.30
    -DI 24.41
    Chandelier Exit (Long, 3 ATRs) 21.99
    Chandelier Exit (Short, 3 ATRs) 23.96
    Upper Bollinger Bands 26.39
    Lower Bollinger Band 20.73
    Percent B (%b) 0.43
    BandWidth 24.01
    MACD Line -0.45
    MACD Signal Line -0.32
    MACD Histogram -0.1289
    Fundamentals Value
    Market Cap 348.43 Million
    Num Shares 15.1 Million
    EPS -8.30
    Price-to-Earnings (P/E) Ratio -2.79
    Price-to-Sales 0.00
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 26.24
    Resistance 3 (R3) 26.04 24.82 25.72
    Resistance 2 (R2) 24.82 24.03 24.91 25.55
    Resistance 1 (R1) 23.98 23.54 24.40 24.17 25.38
    Pivot Point 22.75 22.75 22.96 22.85 22.75
    Support 1 (S1) 21.91 21.96 22.33 22.11 20.90
    Support 2 (S2) 20.69 21.48 20.78 20.73
    Support 3 (S3) 19.85 20.69 20.56
    Support 4 (S4) 20.04